This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schaafsma, H. E. Articles by Ruiter, D. J. Search for Related Content PubMed PubMed Citation Articles by Schaafsma, H. E. Articles by Ruiter, D. J.

American Journal of Pathology, Vol 139, 1389-1400, Copyright © 1991 by American Society for Investigative Pathology

REGULAR ARTICLES

Cytokeratin expression patterns in metastatic transitional cell carcinoma of the urinary tract. An immunohistochemical study comparing local tumor and autologous metastases

HE Schaafsma, FC Ramaekers, GN van Muijen, H Robben, EB Lane, IM Leigh, EC Ooms, JA Schalken, RJ van Moorselaar and DJ Ruiter
Department of Pathology, University Hospital of Nijmegen, The Netherlands.

The cytokeratin (CK) expression patterns of local, ie, primary or recurrent, high-grade-malignant transitional cell carcinomas (TCCs) of the human urinary tract and autologous lymphogenic and hematogenic metastases (n = 33) were compared. Special attention was paid to CK expression in the tumor invasion front and other areas where tumor- stroma interaction occurred to visualize cell populations with a metastatic phenotype. For this purpose, polypeptide-specific monoclonal antibodies to CKs 4, 7, 8, 10, 13, 14, 16, 17, 18, and 19 were used, employing the immunoperoxidase method. Results show that: 1) An increased expression of CK8 and CK18 is seen in the TCC tumor cells at the interface with peritumoral stroma in the tumor invasion front and with intratumoral stroma ('interface phenomenon'). Other than reflecting a quantitative change, this phenomenon might be explained by unmasking of CK8 and CK18 epitopes occurring in these regions. 2) Although in general the expression of CK13 in local TCC is decreased with increase of histopathologic parameters for progression, ie, grade and stage, an extensive proportion of CK13-positive tumor cells still can be found in some TCCs, even in metastases. 3) Morphologically recognizable types of aberrant differentiation in TCC, i.e., pseudosarcomatous or squamous differentiation and marked loss of differentiation, show altered expression of many of the CKs studied.

This article has been cited by other articles:

				Y.-W. Chu, P.-C. Yang, S.-C. Yang, Y.-C. Shyu, M. J. C. Hendrix, R. Wu, and C.-W. Wu Selection of Invasive and Metastatic Subpopulations from a Human Lung Adenocarcinoma Cell Line Am. J. Respir. Cell Mol. Biol., September 1, 1997; 17(3): 353 - 360. [Abstract] [Full Text]

				T. A. Hembrough, L. Li, and S. L. Gonias Cell-surface Cytokeratin 8Is the Major Plasminogen Receptor on Breast Cancer Cells and Is Required for the Accelerated Activation of Cell-associated Plasminogen by Tissue-type Plasminogen Activator J. Biol. Chem., October 11, 1996; 271(41): 25684 - 25691. [Abstract] [Full Text] [PDF]

				T. Hembrough, J Vasudevan, M. Allietta, W. Glass, and S. Gonias A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surfaces of hepatocytes, HepG2 cells and breast carcinoma cell lines J. Cell Sci., January 3, 1995; 108(3): 1071 - 1082. [Abstract] [PDF]

				H. Eto, S. S. Yoon, B. P. Bode, S. Kamidono, K. Makino, H. Saya, H. Nakamura, and K. K. Tanabe Mapping and Regulation of the Tumor-associated Epitope Recognized by Monoclonal Antibody RS-11 J. Biol. Chem., August 25, 2000; 275(35): 27075 - 27083. [Abstract] [Full Text] [PDF]